AGAPE ATP CORPORATION Increase (Decrease) in Due from Other Related Parties, Current
AGAPE ATP CORPORATION (ATPC) reported Increase (Decrease) in Due from Other Related Parties, Current of -$61 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent · last filed 2026-08-14
- AGAPE ATP CORPORATION increase (decrease) in due from other related parties, current for the quarter ending 2026-06-30 was -$404.00.
- AGAPE ATP CORPORATION increase (decrease) in due from other related parties, current for the quarter ending 2026-03-31 was $343.00, a 84.37% decline year-over-year.
- AGAPE ATP CORPORATION increase (decrease) in due from other related parties, current for the quarter ending 2025-12-31 was -$21.00.
- AGAPE ATP CORPORATION increase (decrease) in due from other related parties, current for the quarter ending 2025-09-30 was $1.49K.
- AGAPE ATP CORPORATION increase (decrease) in due from other related parties, current for fiscal 2025 was -$162.00.
- AGAPE ATP CORPORATION increase (decrease) in due from other related parties, current for fiscal 2024 was -$8.89K, a 993.37% decline from fiscal 2023.
- AGAPE ATP CORPORATION increase (decrease) in due from other related parties, current for fiscal 2023 was $995.00, a 73.72% decline from fiscal 2022.
- AGAPE ATP CORPORATION increase (decrease) in due from other related parties, current for fiscal 2022 was $3.79K.
| Period end | Increase (Decrease) in Due from Other Related Parties, Current 3 month | Increase (Decrease) in Due from Other Related Parties, Current 6 month | Increase (Decrease) in Due from Other Related Parties, Current 9 month | Increase (Decrease) in Due from Other Related Parties, Current 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$404.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$61.00 10-Q · filed 2026-08-14 | -$82.00 derived: sum of 3 quarters · filed 2026-08-14 | $1.40K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $343.00 10-Q · filed 2026-05-15 | $322.00 derived: sum of 2 quarters · filed 2026-05-15 | $1.81K derived: sum of 3 quarters · filed 2026-05-15 | -$2.01K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$21.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $1.46K derived: sum of 2 quarters · filed 2026-04-13 | -$2.36K derived: sum of 3 quarters · filed 2026-08-14 | -$162.00 10-K · filed 2026-04-13 |
| 2025-09-30 | $1.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.33K derived: sum of 2 quarters · filed 2026-08-14 | -$141.00 10-Q · filed 2025-11-13 | -$172.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$3.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.63K 10-Q · filed 2026-08-14 | -$1.66K derived: sum of 3 quarters · filed 2026-08-14 | -$3.79K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.19K 10-Q · filed 2026-05-15 | $2.16K derived: sum of 2 quarters · filed 2026-05-15 | $28.00 derived: sum of 3 quarters · filed 2026-05-15 | -$1.02K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$31.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$2.17K derived: sum of 2 quarters · filed 2026-04-13 | -$3.21K derived: sum of 3 quarters · filed 2026-04-13 | -$8.89K 10-K · filed 2026-04-13 |
| 2024-09-30 | -$2.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$3.18K derived: sum of 2 quarters · filed 2025-11-13 | -$8.86K 10-Q · filed 2025-11-13 | -$8.64K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$1.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$6.72K 10-Q · filed 2025-08-13 | -$6.51K derived: sum of 3 quarters · filed 2025-08-13 | -$5.94K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$5.68K 10-Q · filed 2025-05-15 | -$5.46K derived: sum of 2 quarters · filed 2025-05-15 | -$4.89K derived: sum of 3 quarters · filed 2025-05-15 | $4.91K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $213.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $786.00 derived: sum of 2 quarters · filed 2025-03-31 | $10.59K derived: sum of 3 quarters · filed 2025-03-31 | $995.00 10-K · filed 2025-03-31 |
| 2023-09-30 | $573.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $10.38K derived: sum of 2 quarters · filed 2024-11-14 | $782.00 10-Q · filed 2024-11-14 | $11.36K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $9.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $209.00 10-Q · filed 2024-08-14 | $10.78K derived: sum of 3 quarters · filed 2024-08-14 | $6.20K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$9.60K 10-Q · filed 2024-05-14 | $979.00 derived: sum of 2 quarters · filed 2024-05-14 | -$3.61K derived: sum of 3 quarters · filed 2024-05-14 | -$3.60K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $10.57K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $5.99K derived: sum of 2 quarters · filed 2024-04-01 | $5.99K derived: sum of 3 quarters · filed 2024-04-01 | $3.79K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$4.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$4.58K derived: sum of 2 quarters · filed 2023-11-14 | -$6.79K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $6.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$2.20K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$2.21K 10-Q · filed 2023-05-15 | |||
| 2020-12-31 | $2.42K 10-K/A · filed 2022-07-05 | |||
| 2019-12-31 | $2.21K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |